SM
Sonu Meena
About Sonu Meena
Data last updated:
Sonu Meena is a Director at Bloomlife Pharma Private Limited (since 2024) and Director at Betabiopharm Private Limited (since 2022). The companies operate in Environment, Trading and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹68.11 Cr; the largest is Bloomlife Pharma Private Limited at ₹34.06 Cr (FY 2025). Earlier, Sonu Meena was a Director at Bectabiopharma Private Limited (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 May 2024 | 2017 | ₹34.06 Cr (FY 2025) | Active | |
| Director | 07 Oct 2022 | 2022 | ₹34.06 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Apr 2024 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sonu Meena
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kunal Shinde | 11192470 | Bloomlife Pharma Private Limited , Betabiopharm Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sonu Meena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sonu Meena
Sonu Meena currently holds 2 directorships: Bloomlife Pharma Private Limited (Director, since 16 May 2024, revenue ₹34.06 Cr (FY 2025)); Betabiopharm Private Limited (Director, since 07 Oct 2022, revenue ₹34.06 Cr (FY 2025)).
Sonu Meena was first appointed on 07 Oct 2022 as Director at Betabiopharm Private Limited. The most recent appointment on record is 16 May 2024 at Bloomlife Pharma Private Limited.
The 2 current companies of Sonu Meena that report revenue have a combined latest revenue of ₹68.11 Cr: Bloomlife Pharma Private Limited ₹34.06 Cr (FY 2025); Betabiopharm Private Limited ₹34.06 Cr (FY 2025).
Sonu Meena held 1 earlier board appointment: Bectabiopharma Private Limited (Director, 02 Apr 2024 to 03 Nov 2025).
The current boards of Sonu Meena's companies include Kunal Shinde (Bloomlife Pharma Private Limited).